Search
The Deal magazine looks at the biotech sector and how new, creative funding deals are promising to rejuvenate the search for new drugs. Plus, this issue looks at LIBOR's new landscape. Meanwhile, we have an indepth conversation with CD&R's Joseph Rice.
June 18, 2012What goes up must come down, and so it would appear as The Deal magazine examines big-league bankruptcy. The theory holds for Tribune as it's new owners weigh its assets. But what about W.R. Grace, as it emerges from bankruptcy having made 22 acquisitions under protection? Plus, the corporate dealmaker 100.
May 28, 2012The Deal magazine takes an indepth look at the strategic dealmaking of the packaging industry in the middle market. We also hit the road looking at the startup landscape in the drug development and medical devices sectors in Kalamazoo, Michigan as well as the burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries in Bend, Oregon.
May 7, 2012Wanna do M&A? Careful, because here comes the shareholder litigation. When it comes to tech acquisitions, they're getting done -- just too bad companies aren't very good at it. And sovereign wealth funds are back, growing fast.
April 16, 2012No one said private equity would be easy, and our annual Private Equity Deals of the Year proves it again with a roundup of 2011's big winners and losers. Also, The Deal magazine takes a look at cowboy capitalism with a trip to Dallas-Fort Worth. Finally, take a look at our sampling of middle-market companies on the auction block.
April 2, 2012The Deal magazine travels to Japan to witness the island nation rise again amidst an active streak of dealmaking. Plus, a duet of music-related articles look at the antitrust snares of Universal Music's purchase of EMI assets and the effect that the emergence of digital music is having on copyright laws.
March 12, 2012In this issue, The Deal magazine hits the bankruptcy trifecta: the take-no-prisoners battle for Alter Communications; the rise and fall of real estate moguls, the Meruelo brothers; and the bankruptcy league tables. Also, take a look at how Humana has set a new course along the acquisition trail.
February 20, 2012The Deal magazine focuses on the middle market by looking at some of its top dealmakers and then gives an overview of what's out there on the auction block. The issue also features an in-depth look at private equity in France and in emerging markets around the world.
February 6, 2012The Deal magazine gets in the pilot seat to take a look at American Airlines' bankruptcy, then wonders what will now happen to a beleaguered Reader's Digest. Also, Herb Fritch of HealthSpring may have an answer to the sky-high inflation of the healthcare industry.
January 23, 2011What a topsy-turvy, rumbly-tumbly year 2011 turned out to be -- and The Deal magazine takes a look at the M&A Deals of the Year in uncertain times. Also, Edgar Bronfman Jr. sits down for his first interview since selling Warner Music.
December 12, 2011Just when you thought it was safe to go back in the water, suddenly it was 2011 -- and The Deal magazine looks back at all the twists and turns of dealmaking. Also in this issue, dealmakers pay back as social entrepreneurs.
November 28, 2011'What worrying wall of debt?' The Deal magazine asks. Oh, right, there it is. Plus, the Windy City offers up its own particular brand of private equity, while, farther afield, Big Oil makes a play in Kurdistan.
November 14, 2011The Deal magazine tracks down the in-house corporate dealmakers from the top American companies and takes a voyage around the world to explore the valleys and peaks of the travel industry.
October 31, 2011The Deal magazine goes back to school and offers a full report on the business of education.
October 17, 2011The Deal magazine goes looking for trolls and geeks, and the middle market shows its ups and downs in a trying economy.
October 3, 2011Who are the private equity movers and shakers to keep an eye on, and how does Ralph de la Torre look to transform managed care?
September 19, 2011The Deal magazine honors this year's Most Admired Corporate Dealmakers and takes a close look at the ups and downs of Wall Street compensation.
September 5, 2011The interview issue asks all the pertinent questions to six experts in their respective fields, while the market for multiple sclerosis therapies provides an evocative case study on dealmaking.
July 25, 2011The Deal magazine gets up close and personal with faces of the middle market and charts the new hits of the music business as it shifts away from label dominance.
June 27, 2011Despite trying financial times, the spotlight shines on the private equity deals of the year that were deftly executed and held to the principle of creating value.
"This is a good opportunity for people in the deal community to actually weigh in on companies that they've observed over time do an outstanding job in selecting M&A targets," explains Suzanne Miller, The Deal's Corporate Dealmaker editor.
The Deal editor at large Matt Miller chats with Restorm's Phillippe Perreaux about music licensing in Europe.
Dealmaking volumes have been mediocre since last fall, stirring talk of a secular decline. Don't bet on it.
While both deals faced hurdles to pass antitrust muster, Express Scripts has made a more traditional, subtle lobbying effort.
The CEO of the midmarket biotech talks about such topics as the FDA's approval process for biosimilars and the coming battle for U.S. market share of generic biologics.
The firm, which specializes in technology and defense, is racking up deal mandates.
Five former Morgan Stanley dealmakers hit the ground running at Dean Bradley Osborne.
The former M&A banker wants the government to come clean about the true scope of the nation's debt.
Big Brown buys its Dutch peer, Cisco gets back into the deal game, and Zayo adds the 19th notch to its acquisition belt.
We need you to tell us who's the best at M&A.
The Co-op could yet emerge as a serious challenger if it acquires certain Lloyds branches and assets.
The former 3Com engineer take his efforts to meld technological know-how with market savvy up a notch by joining Onset Ventures as a venture adviser.
The high-profile former BofA banker moves to the Swiss bank as it tries to put bad credit bets and a rogue-trading scandal behind it.
Armed with ample cash and a strong yen, Japanese firms are active — and careful — acquirers.
Read a round-up of some of Japan's most active dealmakers, including Takeda Pharmaceutical's Yasuchika Hasegawa, DC Advisory's Tosh Kojima, Simpson Thacher's David Sneider and others.
The rise of digital music raises all kinds of issues for a copyright law last substantially redone in 1976. The result: bad blood, litigation and M&A.
The sale of EMI has raised antitrust concerns, particularly after Universal Music scooped up the recorded-music assets.
Morgan Stanley's James Gorman was smoking hot over the attack upon Goldman Sachs by an escaping employee.
Reuters tries to rescue the Stabby Banker from the stereotype of Sherman McCoy as a Master of the Universe. First, it should get the reference correct.
In the case, Delaware again signals its discomfort with controlling shareholders who demand a little something extra when negotiating a sale.
Two recent rulings by the regulator illustrate the potential hurdles Google and other buyers face when trying to clear mergers in China.
Teacher Retirement System of Texas and New Jersey's State Investment Council have fine-tuned PE allocations by devising SMAs.
Many large PE shops are diversifying their platforms by offering new, complementary products as fixed-income firms diversify into PE.
Three cases decided in 2011 go a long way toward minimizing the uncertainty created by the revised guidelines.
Why does Ireland continue to be one of the most favored foreign direct investment locations for U.S. companies?
